News

January 20, 2021January 20, 2021

Tenax Buys PH Precision Med, Plans Trial for Oral Imatinib

News, PAH News

Tenax Therapeutics has acquired PH Precision Med (PHPM), a private biotech focused on developing imatinib as a treatment for pulmonary arterial hypertension (PAH). “The acquisition of PHPM immediately expands ... Read more

January 18, 2021January 18, 2021

Tyvaso Improves Exercise Capacity in PH-ILD Patients, Study Finds

News, PH News

Nebulizer treatment with Tyvaso (inhaled treprostinil) can improve exercise capacity in people with pulmonary hypertension associated with interstitial lung disease (PH-ILD), a study reports. The study, “Inhaled Treprostinil in ... Read more

January 15, 2021January 15, 2021

HealthWell Foundation Offering Grants to Offset Cost of PH Treatments

News, PH News

The HealthWell Foundation has opened a fund to help people with pulmonary hypertension (PH) in the U.S. who are on Medicare with covering their healthcare costs. The fund will offer ... Read more

January 13, 2021January 13, 2021

Prolargin Shows Early Promise as PAH Biomarker

News

The prolargin protein may serve as a biomarker for pulmonary arterial hypertension (PAH), allowing for earlier diagnosis and differentiating among different types of pulmonary hypertension (PH), according to a ... Read more

January 12, 2021January 12, 2021

NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum

News, syndicated

The National Organization for Rare Disorders (NORD) is seeking individuals willing to share real-life experiences with rare diseases to speak at its upcoming virtual Living Rare, Living Stronger NORD ... Read more

January 11, 2021January 11, 2021

Novel Gene Implicated in PH Development in Preclinical Study

News, PH News

A gene called DNMT3B was found for the first time to be a mediator of blood vessel wall growth, and has been implicated in the development of pulmonary hypertension (PH) ... Read more

January 8, 2021January 8, 2021

High Creatinine, NT-proBNP Levels Found to Be Mortality Risk Factors

News, PAH News

Elevated blood levels of the kidney disease biomarker creatinine and the heart failure biomarker NT-proBNP were found to be independent predictors of mortality for older people with pulmonary arterial ... Read more

January 6, 2021January 6, 2021

FDA Priority Review Likely for Tyvaso DPI, Inhaled Treprostinil for PAH

News

United Therapeutics is planning to ask the U.S. Food and Drug Administration (FDA) for an accelerated review of Tyvaso DPI, an investigational therapy-inhaler device treatment for two forms of pulmonary hypertension, ... Read more

January 4, 2021January 4, 2021

Atrial Flow Regulator Receives FDA’s Breakthrough Device Designation

News, PAH News

Occlutech’s atrial flow regulator (AFR) — a cardiac implant — received breakthrough device designation from the U.S. Food and Drug Administration for the treatment of pulmonary arterial hypertension (PAH). ... Read more